273 related articles for article (PubMed ID: 11465718)
1. Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases.
Gündüz OH; Fertig N; Lucas M; Medsger TA
Arthritis Rheum; 2001 Jul; 44(7):1663-6. PubMed ID: 11465718
[TBL] [Abstract][Full Text] [Related]
2. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
4. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA
J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
[TBL] [Abstract][Full Text] [Related]
5. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
[TBL] [Abstract][Full Text] [Related]
6. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
7. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
Steen V; Medsger TA
Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
[TBL] [Abstract][Full Text] [Related]
8. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma renal crisis: patient characteristics and long-term outcomes.
Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
[TBL] [Abstract][Full Text] [Related]
10. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
Steen VD; Medsger TA
Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
[TBL] [Abstract][Full Text] [Related]
11. Renal complications and scleroderma renal crisis.
Denton CP; Lapadula G; Mouthon L; Müller-Ladner U
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii32-5. PubMed ID: 19487221
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
[TBL] [Abstract][Full Text] [Related]
13. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
15. Renal function is mostly preserved in patients with systemic sclerosis.
Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
Harvey G; Black C; Maddison P; McHugh N
J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
Hasegawa M; Sato S; Yanaba K; Komura K; Yamazaki M; Takehara K
Ann Rheum Dis; 2004 Nov; 63(11):1514-7. PubMed ID: 15479907
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
Poormoghim H; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary-renal syndrome in systemic sclerosis.
Bar J; Ehrenfeld M; Rozenman J; Perelman M; Sidi Y; Gur H
Semin Arthritis Rheum; 2001 Jun; 30(6):403-10. PubMed ID: 11404823
[TBL] [Abstract][Full Text] [Related]
20. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
Steen VD; Medsger TA
Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
